Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table3-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Modeling the Effects of Multiple Myeloma on Kidney Function | Scientific Reports
Table 5 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Cureus | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management | Article
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
5/7/2018 1 MULTIPLE MYELOMA: WHAT'S NEW?
Table 1 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Distribution of serum FLC and kappa/lambda ratio in patients with renal... | Download Table
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
